Metastatic endocervical adenocarcinoma presenting as a virilizing ovarian mass during pregnancy

Obstetrics and Gynecology

Volumn 100, Issue 5 SUPPL., 2002, Pages 1129-1133

  Powell, John L ^a   Bock, Kimberly A ^a   Gentry, Jason K ^a   White, Warren C ^a   Ronnett, Brigitte M ^b  

^a New Hanover Regional Medical Center   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; VIRUS DNA;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CASE REPORT; CESAREAN SECTION; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IN SITU HYBRIDIZATION; METASTASIS; OVARY CARCINOMA; PREGNANCY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERINE CERVIX CARCINOMA; VIRILIZATION; VIRUS DETECTION; WART VIRUS;

ADULT; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CERVICAL NEOPLASMS; VIRILISM;

EID: 0036848077     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02205-6     Document Type: Article

References (10)

1. Scully R.E., Young R.H., Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. 1998;373-378 Armed Forces Institute of Pathology, Washington. AFIP Atlas of Tumor Pathology, 3rd Ser., fasc. 23.
2. DePalma P., Wronski M., Bifernino V., Bovani I. Krukenberg tumor in pregnancy with virilization. Eur J Gynaecol Oncol. 16:1995;59-64.
3. Fung M.F., Vadas G., Lotocki R., Heywood M., Krepart G. Tubular Krukenberg tumor in pregnancy with virilization. Gynecol Oncol. 41:1991;81-84.
4. Connor T.B., Ganis F.M., Levin H.S., Migeon C.J., Martin L.G. Gonadotropin-dependent Krukenberg tumor causing virilization during pregnancy. J Clin Endocrinol Metab. 28:1968;198-214.
5. Staebler A., Sherman M.E., Zaino R.J., Ronnett B.M. Hormone receptor immunohistochemistry and HPV in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol. 26:2002;998-1006.
6. Fujiwara H., Tortolero-Luna G., Mitchell M.F., Koulos J.P., Wright T.C.J. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer. 79:1997;505-512.
7. Ghandour F.A., Attanoos R., Nahar K., Gee J.W., Bigrigg A., Ismail S.M. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology. 24:1994;49-55.
8. Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G., et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 157:2000;1055-1062.
9. Andersson S., Rylander E., Larsson B., Strand A., Silfversvard C., Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer. 37:2001;246-250.
10. Antilla M., Syrjanen S., Ji H., Saarikoski S., Syrjanen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol. 72:1999;337-341.